Sutro Biopharma, Inc.STRONASDAQ
LOADING
|||
Switch Symbol:
Revenue Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year revenue growth rate
Latest
-84.79%
↓ 308% below average
Average (34q)
40.74%
Historical baseline
Range
High:571.95%
Low:-88.56%
Volatility
1621.1%
High variability
| Period | Value |
|---|---|
| Q3 2025 | -84.79% |
| Q2 2025 | 266.37% |
| Q1 2025 | 17.49% |
| Q4 2024 | 73.81% |
| Q3 2024 | -66.86% |
| Q2 2024 | 97.62% |
| Q1 2024 | -88.56% |
| Q4 2023 | 571.95% |
| Q3 2023 | 62.54% |
| Q2 2023 | -17.85% |
| Q1 2023 | 46.83% |
| Q4 2022 | -65.67% |
| Q3 2022 | -10.50% |
| Q2 2022 | 376.45% |
| Q1 2022 | -44.65% |
| Q4 2021 | 25.09% |
| Q3 2021 | -69.64% |
| Q2 2021 | 91.33% |
| Q1 2021 | 77.10% |
| Q4 2020 | -53.55% |
| Q3 2020 | 88.22% |
| Q2 2020 | 32.40% |
| Q1 2020 | -36.74% |
| Q4 2019 | -7.92% |
| Q3 2019 | 16.65% |
| Q2 2019 | 21.97% |
| Q1 2019 | -54.79% |
| Q4 2018 | 143.57% |
| Q3 2018 | 37.38% |
| Q2 2018 | -1.54% |
| Q1 2018 | 43.39% |
| Q4 2017 | -76.91% |
| Q3 2017 | 15.88% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |